Business context and reporting period
The Marygold Companies, Inc. (NYSE American: MGLD) filed this Form 8-K to report a proposed acquisition and amendments to its bylaws. The report is dated September 24, 2026, while the merger agreement and related stockholder consent are dated September 25, 2026; the filing was signed September 28, 2026. This is a transaction filing, not a periodic financial-results report.
Key transaction terms and financial information
- Flower AcquireCo, LLC, controlled by funds managed by Madison Dearborn Partners, LLC, will acquire the Company through a merger. The Company will survive as a wholly owned subsidiary and become privately held; its common stock is expected to be delisted from NYSE American.
- Most outstanding common shares will convert into $2.00 per share in cash, without interest. The stated price represents an approximately 100% premium to the September 24, 2026 closing price. Treasury shares, shares held by Parent or Merger Sub, and certain rollover shares are excluded.
- Preferred shares will receive cash based on the number of common shares into which they are convertible. In-the-money options will receive cash for their spread over the $2.00 price, less withholding; options at or above that exercise price and warrants at or above it will be cancelled for no consideration. Restricted stock awards will be cashed out at $2.00 per share, less withholding.
- Parent has equity financing commitments, and closing is not subject to a financing condition. The filing does not provide aggregate transaction proceeds or current revenue, earnings, cash flow, margins, debt, or liquidity figures.
Material changes and status
- Stockholders representing approximately 75% of voting power entered into voting and support agreements and delivered written consent approving the merger. The required stockholder approval is therefore satisfied, and the agreement’s alternative-proposal provisions described in the filing have expired.
- The Board, acting on the unanimous recommendation of its independent Special Committee, unanimously approved the merger agreement and recommended approval by stockholders.
- The Company’s board adopted a bylaw amendment effective September 24, 2026, adding director and officer indemnification provisions, exclusive-forum rules for specified internal and Securities Act claims, deemed stockholder notice and consent language, and an opt-out from Nevada’s controlling-interest acquisition statutes. The Company also entered into customary indemnification agreements with directors and certain senior officers.
Outlook, conditions, and risks
The transaction is expected to close in the first half of 2027 or earlier. Closing remains subject to customary conditions, including the 20-calendar-day period after mailing the definitive information statement, applicable fund and regulatory approvals, approvals relating to certain fund wind-downs, U.K. Financial Conduct Authority approval for divestiture of certain U.K. subsidiaries, and other contractual conditions. The Company expects to file preliminary and definitive Schedule 14C information statements. The agreement may be terminated in specified circumstances, including if closing has not occurred by June 7, 2027, subject to possible extension; a termination fee of approximately $2.6 million may be payable in certain circumstances. The filing states that stockholders are not entitled to appraisal or dissenters’ rights. Risks include failure to obtain remaining approvals or satisfy closing conditions, delay or failure to close, termination, and potential litigation. The filing contains no operating or earnings guidance.
Important facts for investors to verify
- Review the merger agreement, voting and support agreements, and Schedule 14C information statement, including transaction conditions, termination rights, and the treatment of each security class.
- Monitor remaining regulatory and fund-related approvals, the information-statement mailing and waiting period, and any transaction litigation or amendments.
- Confirm the final closing date, any extension of the termination date, and the resulting delisting and deregistration steps.
- Verify the company’s financial position and any aggregate consideration or proceeds in other filings; this 8-K does not provide those figures.